Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,220.00
0.00 (0.00%)
Sep 11, 2026, 3:30 PM KST

Bio Plus Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
13,84615,00114,15125,58121,13710,725
Depreciation & Amortization
4,5124,0633,2702,4901,8871,298
Loss (Gain) From Sale of Assets
36.0735.53-592.748.52109.06-
Asset Writedown & Restructuring Costs
74.4974.49---1,565
Loss (Gain) From Sale of Investments
-234.36-326.27-87.62-41.03-639.04-
Loss (Gain) on Equity Investments
-7.57178.28--311.08327.99
Stock-Based Compensation
--66.39188.3945035.98
Provision & Write-off of Bad Debts
3,6724,2821,5501,025-265.58268.08
Other Operating Activities
4,003-269.535,913-2,6622,8283,176
Change in Accounts Receivable
-186.27939.544,601-5,255-8,671-3,628
Change in Inventory
-4,428-5,705-1,4922,339-4,158-66.02
Change in Accounts Payable
-94.09-392.16403.41-717.63157.89219.49
Change in Unearned Revenue
----260--
Change in Income Taxes
-72-79.8-29.01-0.11-0.21-
Change in Other Net Operating Assets
-2,513-147.27-1,267-2,408213.89-569.51
Operating Cash Flow
18,60917,65526,48720,28913,35913,352
Operating Cash Flow Growth
-14.21%-33.34%30.55%51.87%0.05%32.95%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-18,870-46,582-94,999-21,092-6,530-15,312
Sale of Property, Plant & Equipment
-474.53141,048-5-
Cash Acquisitions
-27.55-34.16----
Divestitures
--76.022,103-0.29
Sale (Purchase) of Intangibles
-1,235-1,346-1,143-479.64-164.26-46.05
Investment in Securities
-2,374-1,42412,77241,181-60,360-5,700
Other Investing Activities
-1,341-150.27-150.24-67.83-121.16-212.24
Investing Cash Flow
-24,328-49,528-84,36421,728-67,130-22,634

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-4,0768,196---
Long-Term Debt Issued
-1,87759,699---
Total Debt Issued
18,4155,95267,896---
Short-Term Debt Repaid
--4,261-3,556-1,040--274.38
Long-Term Debt Repaid
--1,286-820.78-715.04-612.77-289.99
Total Debt Repaid
-15,954-5,547-4,377-1,755-612.77-564.37
Net Debt Issued (Repaid)
2,461405.5263,519-1,755-612.77-564.37
Issuance of Common Stock
9,86810,359-30012,47845,500
Repurchase of Common Stock
-1,499-1,499-4,990-4,990-1,186-8,793
Common Dividends Paid
-4,290-2,916-4,197-4,249--
Other Financing Activities
-601.22341.06-350-3,767-15-2,098
Financing Cash Flow
13,39814,15149,522-14,46130,65934,045

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
539.58156.891,02395.82434.57271.96
Miscellaneous Cash Flow Adjustments
00-0-0-00
Net Cash Flow
8,219-17,565-7,33127,653-22,67725,035

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-261.24-28,927-68,513-803.376,829-1,959
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.26%-31.82%-103.17%-1.23%12.04%-5.24%
Free Cash Flow Per Share
-4.00-422.81-1195.85-13.26119.07-37.80
Levered Free Cash Flow
-27,423-70,135-36,701-5,0841,141-6,383
Unlevered Free Cash Flow
-27,234-69,945-36,536-5,0461,149-6,057

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
235.2172.54128.25146.055.8851.21
Cash Income Tax Paid
2,5802,3654,6178,3772,8932,863
Change in Working Capital
-7,293-5,3852,217-6,300-12,458-4,044